Debt & Credit Markets

Crescent's largest-ever fund close highlights booming investor appetite for private credit and promises a major capital infusion for the U.S. lower middle market.

The new fund from Loomis Sayles and Natixis enters the booming interval fund market, offering access to private credit amid growing regulatory scrutiny.

Facing default, the Brazilian mall operator offers a risky swap of distressed bonds for fund shares, forcing a tough choice on international investors.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

Baxter is buying back billions in debt, a strategic move to clean its balance sheet. But with operational issues mounting, is it enough to win back investors?